Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells
about
ATF4 is a mediator of the nutrient-sensing response pathway that activates the human asparagine synthetase geneCrystal structure of active site mutant of antileukemic L-asparaginase reveals conserved zinc-binding siteRecombinant L-asparaginase 1 from Saccharomyces cerevisiae: an allosteric enzyme with antineoplastic activityComparison of native E. coli and PEG asparaginase pharmacokinetics and pharmacodynamics in pediatric acute lymphoblastic leukemia.The glutaminase activity of L-asparaginase is not required for anticancer activity against ASNS-negative cells.A conserved glutamate controls the commitment to acyl-adenylate formation in asparagine synthetaseAsnB is involved in natural resistance of Mycobacterium smegmatis to multiple drugsAsparagine synthetase: regulation by cell stress and involvement in tumor biologyAsparagine plays a critical role in regulating cellular adaptation to glutamine depletionAsparagine synthetase chemotherapy.Polymorphisms of asparaginase pathway and asparaginase-related complications in children with acute lymphoblastic leukemia.An inhibitor of human asparagine synthetase suppresses proliferation of an L-asparaginase-resistant leukemia cell line.A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivity.Auto-activation of c-JUN gene by amino acid deprivation of hepatocellular carcinoma cells reveals a novel c-JUN-mediated signaling pathway.Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase.Establishment of real-time polymerase chain reaction method for quantitative analysis of asparagine synthetase expressionATF5 polymorphisms influence ATF function and response to treatment in children with childhood acute lymphoblastic leukemia.Identification of genomic classifiers that distinguish induction failure in T-lineage acute lymphoblastic leukemia: a report from the Children's Oncology Group.Nutritional control of gene expression: how mammalian cells respond to amino acid limitation.Interaction of RNA-binding proteins HuR and AUF1 with the human ATF3 mRNA 3'-untranslated region regulates its amino acid limitation-induced stabilization.The transcription factor network associated with the amino acid response in mammalian cells.Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinomaFilamentation of Metabolic Enzymes in Saccharomyces cerevisiae.A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells.Metabolic Alterations Caused by KRAS Mutations in Colorectal Cancer Contribute to Cell Adaptation to Glutamine Depletion by Upregulation of Asparagine Synthetase.Optimized CGenFF force-field parameters for acylphosphate and N-phosphonosulfonimidoyl functional groups.Cancer-stromal interactions: role in cell survival, metabolism and drug sensitivity.CCAAT/enhancer-binding protein-beta is a mediator of the nutrient-sensing response pathway that activates the human asparagine synthetase gene.Genetic alterations determine chemotherapy resistance in childhood T-ALL: modelling in stage-specific cell lines and correlation with diagnostic patient samples.Drug-induced amino acid deprivation as strategy for cancer therapy.Differential mechanisms of asparaginase resistance in B-type acute lymphoblastic leukemia and malignant natural killer cell linesDown-regulation of asparagine synthetase induces cell cycle arrest and inhibits cell proliferation of breast cancer.Asparagine depletion potentiates the cytotoxic effect of chemotherapy against brain tumors.Safety, efficacy, and clinical utility of asparaginase in the treatment of adult patients with acute lymphoblastic leukemia.Curcumin potentiates antitumor activity of L-asparaginase via inhibition of the AKT signaling pathway in acute lymphoblastic leukemia.Amino-acid limitation induces transcription from the human C/EBPbeta gene via an enhancer activity located downstream of the protein coding sequence.Effects of naturally occurring polymethyoxyflavonoids on cell growth, p-glycoprotein function, cell cycle, and apoptosis of daunorubicin-resistant T lymphoblastoid leukemia cells.Selective apoptosis of natural killer-cell tumours by l-asparaginase.Human CCAAT/enhancer-binding protein beta gene expression is activated by endoplasmic reticulum stress through an unfolded protein response element downstream of the protein coding sequence.The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation.
P2860
Q24294712-4A936D3F-9C8D-438D-9D76-86C66B7E5119Q27694569-B2382A54-73B6-46FD-B060-80BF1F7CD8FAQ28114319-6A7AA182-C4A2-476C-BCD5-431E0392662EQ33701864-F1100B2E-8A9A-4382-9564-47F477944745Q33718822-60E96097-979C-466A-A5C8-EC6939C84415Q34284425-2B02A674-4127-4F77-BCC8-266EFBF4434BQ34301633-C2D3F5BA-6C30-4217-943D-1A8C64E2B1E2Q34327474-D391F604-8323-4FAA-8AE1-9C2A69508269Q34473984-3ECBC20B-5A50-4B32-9701-2C32483ABA0AQ34535185-C6263350-4908-4431-9E82-1E94E18353D7Q34644733-D4AFFB4D-F1AF-4868-BDF9-CC2B809E58C2Q34653242-BBAF5386-F1D8-4991-9FB0-38B4CEC89048Q34989475-437B1D07-E926-47EB-827C-86ED0B12C6E3Q35379187-9674E1B9-67FA-4547-B4F7-488E5F986882Q35677647-666E9205-1C8F-4326-9EF9-5ABA43357C47Q35790343-335DB483-0131-4336-A3D1-2CAC1FDD9E6DQ35930217-7DC6A9F2-D215-4E3D-851A-FC86FB708F42Q35989408-2966F20E-31E7-40B3-B907-C9EDEB859EC3Q36191074-BFFC5233-7E7A-4331-B288-47215FFF5811Q36692512-6C5AC7FD-B1D6-4D51-8F67-B902F743D3DBQ36830376-1455C0E5-33AE-4975-9BCB-7E89EADD4F18Q37003403-9DD16653-2F88-4327-BF30-3321C5246322Q37037776-BAE712A0-A60F-4451-BCBD-60E2293FFA13Q37109747-77E8AC40-12BA-42B5-BD1D-4911110524C3Q37352111-CC9B999B-5726-40C4-89D2-690A6F11B28FQ37524043-EB72E871-47D7-48C3-BB86-27985CC36157Q37824564-482F332C-B441-47C2-A49C-C0837BB1E785Q38295423-EA5ABCF1-E16C-440B-B29D-BCCEE13708A1Q38298331-E99D7D83-968B-44E5-83E1-3640C2353CD1Q38657061-4A4FB36E-767C-40A1-BE82-30DEE2EACD83Q38915906-12D4375A-075A-4219-B503-FB349BF9619AQ39000725-2CD73A6B-A1B1-4531-B896-224862EF5F4FQ39026261-E4E6834D-7536-45A4-B623-DDBCE0CF8F25Q39194553-28E32108-BF7F-4AFF-818A-B371DDAD9440Q39425215-1DA4AC77-966F-4A84-B0B5-A030A0368135Q39499496-A0709A4A-7851-4A7C-BC4D-5909D0B33306Q39782495-76A219EE-CBB3-48C4-A18E-043A97D6892CQ40374756-70FF2505-E8C3-4DC9-8B3D-1022AEF4AD49Q40563931-EBA01FE3-4BB5-4F6E-8164-F9317CA868AFQ41465002-7CF36F90-58E0-42DF-8512-85F5D15DB9E4
P2860
Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Asparagine synthetase expressi ...... n MOLT-4 human leukaemia cells
@ast
Asparagine synthetase expressi ...... n MOLT-4 human leukaemia cells
@en
Asparagine synthetase expressi ...... n MOLT-4 human leukaemia cells
@nl
type
label
Asparagine synthetase expressi ...... n MOLT-4 human leukaemia cells
@ast
Asparagine synthetase expressi ...... n MOLT-4 human leukaemia cells
@en
Asparagine synthetase expressi ...... n MOLT-4 human leukaemia cells
@nl
prefLabel
Asparagine synthetase expressi ...... n MOLT-4 human leukaemia cells
@ast
Asparagine synthetase expressi ...... n MOLT-4 human leukaemia cells
@en
Asparagine synthetase expressi ...... n MOLT-4 human leukaemia cells
@nl
P2093
P2860
P3181
P1433
P1476
Asparagine synthetase expressi ...... n MOLT-4 human leukaemia cells
@en
P2093
A M Aslanian
B S Fletcher
M S Kilberg
P2860
P3181
P356
10.1042/0264-6021:3570321
P407
P577
2001-07-01T00:00:00Z